Questions discussed in this category
For example, anticoagulation for recent, significant PE or dual antiplatelet therapy for recent MI, but requiring urgent procedures such as biopsy of ...
Is there an absolute cutoff for AST/ALT that you use where the risks outweigh the potential harm reduction benefits of using the medication? &nbs...
If you prefer monitoring strategy, how frequently do you repeat labs and what is your referral thresholds to hepatology if you're practicing in primar...
Do you prescribe it universally or based on specific risk factors?
For example, what do you do when someone requests aggressive, life-prolonging treatments but then is not receptive to elements of day-to-day care in t...
Are there situations in which you would continue the possible offending agent with close monitoring?
How would your recommendation change if the patient has H63 homozygous mutation?
For example, would you consider alternatives to paracentesis (Denver shunt placement, CART therapy, or permanent tunneled catheters) that might better...
249122493526159266242491526081236762474311930249852491119815237052304923665
Papers discussed in this category
European journal of endocrinology, 2023 Aug 02
Drug and alcohol dependence, 2024 Sep 07
JAMA psychiatry, 2025 Apr 01
The New England journal of medicine, 2021 Mar 04
JHEP reports : innovation in hepatology, 2024 Apr 10